A detailed history of Envestnet Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Envestnet Asset Management Inc holds 4,278,660 shares of NVO stock, worth $364 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,278,660
Previous 4,254,180 0.58%
Holding current value
$364 Million
Previous $607 Million 16.1%
% of portfolio
0.17%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $2.91 Million - $3.56 Million
24,480 Added 0.58%
4,278,660 $509 Million
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $7.23 Million - $8.66 Million
58,935 Added 1.4%
4,254,180 $607 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $1.91 Million - $2.55 Million
-18,733 Reduced 0.44%
4,195,245 $539 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $29.7 Million - $35.7 Million
-338,503 Reduced 7.44%
4,213,978 $436 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $253 Million - $555 Million
2,779,866 Added 156.82%
4,552,481 $414 Million
Q2 2023

Aug 04, 2023

SELL
$155.98 - $172.65 $552 Million - $611 Million
-3,536,251 Reduced 66.61%
1,772,615 $287 Million
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $468 Million - $563 Million
3,537,248 Added 199.66%
5,308,866 $845 Million
Q4 2022

Feb 07, 2023

SELL
$102.55 - $135.33 $3.37 Million - $4.45 Million
-32,848 Reduced 1.82%
1,771,618 $240 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $301,561 - $370,083
-3,165 Reduced 0.18%
1,804,466 $180 Million
Q2 2022

Aug 03, 2022

BUY
$103.24 - $121.81 $21.1 Million - $24.8 Million
203,998 Added 12.72%
1,807,631 $201 Million
Q1 2022

May 04, 2022

BUY
$93.1 - $112.54 $17.3 Million - $20.9 Million
186,122 Added 13.13%
1,603,633 $178 Million
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $7.24 Million - $8.84 Million
75,538 Added 5.63%
1,417,511 $159 Million
Q3 2021

Oct 07, 2021

BUY
$84.42 - $106.62 $3.56 Million - $4.49 Million
42,140 Added 3.24%
1,341,973 $129 Million
Q2 2021

Aug 04, 2021

BUY
$67.66 - $84.76 $3.44 Million - $4.31 Million
50,877 Added 4.07%
1,299,833 $109 Million
Q1 2021

May 04, 2021

BUY
$67.06 - $75.82 $5.15 Million - $5.82 Million
76,766 Added 6.55%
1,248,956 $84.2 Million
Q4 2020

Feb 02, 2021

BUY
$63.89 - $73.8 $976,111 - $1.13 Million
15,278 Added 1.32%
1,172,190 $81.9 Million
Q3 2020

Oct 09, 2020

SELL
$63.69 - $70.22 $549,326 - $605,647
-8,625 Reduced 0.74%
1,156,912 $80.3 Million
Q2 2020

Jul 08, 2020

BUY
$58.54 - $67.94 $2.27 Million - $2.63 Million
38,756 Added 3.44%
1,165,537 $76.3 Million
Q1 2020

Apr 23, 2020

BUY
$49.46 - $64.78 $3.72 Million - $4.87 Million
75,115 Added 7.14%
1,126,781 $67.8 Million
Q4 2019

Feb 11, 2020

BUY
$49.86 - $58.26 $1.33 Million - $1.56 Million
26,722 Added 2.61%
1,051,666 $60.9 Million
Q3 2019

Oct 17, 2019

BUY
$47.54 - $53.43 $1.88 Million - $2.12 Million
39,610 Added 4.02%
1,024,944 $53 Million
Q2 2019

Aug 02, 2019

BUY
$46.79 - $52.47 $1.07 Million - $1.2 Million
22,950 Added 2.38%
985,334 $50.3 Million
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $1.39 Million - $1.57 Million
-29,891 Reduced 3.01%
962,384 $50.3 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $16.9 Million - $19.3 Million
407,841 Added 69.78%
992,275 $45.7 Million
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $1.91 Million - $2.1 Million
-40,915 Reduced 6.54%
584,434 $27.6 Million
Q2 2018

Aug 10, 2018

BUY
$44.29 - $50.42 $25 Million - $28.5 Million
565,395 Added 943.05%
625,349 $28.8 Million
Q1 2018

May 09, 2018

SELL
$48.49 - $58.14 $52.7 Million - $63.2 Million
-1,086,601 Reduced 94.77%
59,954 $2.94 Million
Q4 2017

Feb 20, 2018

BUY
$47.53 - $53.73 $393,833 - $445,206
8,286 Added 0.73%
1,146,555 $61.5 Million
Q3 2017

Nov 13, 2017

SELL
$41.15 - $49.22 $1.22 Million - $1.46 Million
-29,692 Reduced 2.54%
1,138,269 $54.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,167,961
1,167,961 $50.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.